Billings Clinic
Especially For:

Clinical Trials

Title   Lung Cancer: S0709 Advanced NSCLC Stage IIIB or IV, First Line
Description   A PHASE II SELECTION DESIGN OF PHARMACODYNAMIC SEPARATION OF
CARBOPLATIN/PACLITAXEL/OSI-774 (ERLOTINIB; NSC-718781) OR OSI-774 ALONE IN ADVANCED
NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS WITH PERFORMANCE STATUS 2 (PS-2)
IRB Number   S0709
Category   Lung Cancer
Status   Active
Principal Investigator (PI)   Jorge Nieva, MD
Contact Name   Judy Miller, RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.